On May 15, 2020, the Prime Minister announced $450 million in funding to help Canada’s academic research community during the COVID-19 pandemic. The investment is designed to do the following.
- Provide wage supports to universities and health research institutes, so they can retain research staff who are funded from industry or philanthropic sources and are unable to access some of the government’s existing COVID-19 support measures. The government will provide up to 75 per cent of the eligible portion of eligible research personnel’s wages, with a maximum of $847 per week for up to 12 weeks per individual, within the eligibility period of March 15, 2020 to August 29, 2020.
- Support universities and health research institutes to maintain essential research-related activities during the crisis, and to ramp back up to full research operations once physical distancing measures are eased. This will cover up to 75 per cent of total eligible costs, and will support activities such as the safe storage of dangerous substances, and restarting data sets that were interrupted during the pandemic.
The Canada Research Continuity Emergency Fund (CRCEF) was launched by the Tri-Agency Institutional Programs Secretariat (TIPS) a few weeks later on June 23.
The University of Toronto & Affiliated Health Care Institutions Benefiting from CRCEF
Collectively, the University of Toronto and its affiliated hospitals/research institutes undertake a significant proportion of Canada’s academic research activity. The research enterprise at each of our institutions has been severely impacted by COVID-19, and we are deeply appreciative that the Government of Canada has recognized this negative impact in the creation of the Canada Research Continuity Emergency Fund. This funding will help us to maintain staff and essential activities during pandemic-related slowdown of, or interruption to, research and as we resume full research operations in new circumstances.
In addition to academic divisions of the University of Toronto, the following affiliated health care institutions are benefitting from CRCEF:
- Baycrest Centre for Geriatric Care
- Centre for Addiction and Mental Health
- Holland Bloorview Kids Rehabilitation Hospital
- North York General Hospital
- Sinai Health System
- Sunnybrook Research Institute
- The Hospital for Sick Children
- Trillium Health Partners
- Unity Health Toronto
- University Health Network
- Women’s College Hospital
Method of Distribution of CRCEF Funds Across Our Institutions
Stages 1 & 2
Upon confirmation by TIPS of program specifications for the CRCEF program, the University of Toronto and its Toronto Academic Health Science Network (TAHSN) affiliated institutions moved quickly to establish discussion tables to ensure coordination and consistency in responding to this important opportunity. Together, we established a CRCEF Steering Committee, comprising representatives of the hospital research institutes and the University, complemented by a TAHSN CRCEF Data Working Group, comprising financial/research operations representatives of each of the twelve institutions. Each group is diverse in its make-up and all members of each group have undertaken unconscious bias training.
The University undertook analysis to determine “notional allocations” across the 12 institutions, using to the full extent possible the CAUBO-informed formula/data applied by TIPS in determining our Stage 1 allocation of $41.6M. The allocations and supporting data were shared with affiliates. Open and transparent exchange of information has been a cornerstone of engagement throughout the process, consistent with our approach to all matters of shared interest over many years. Together, and in consultation with TIPS, the 12 institutions confirmed a common approach to determining CRCEF-eligible funding sources and FTE.
Given the timing of the receipt of the Stage 1 payment by TIPS to the University of Toronto, all twelve institutions were able to complete their Stage 1 and 2 eligible wage subsidy analyses, rendering data regarding the eligible head count and wage subsidy expense for both Stages 1 and 2. This enabled the University to clarify the exact amounts required at each Stage for each institution. In a few cases, institutions required less than the CAUBO-informed Stage 1 amount, which was reallocated on a pro-rata basis to those institutions that required additional funds beyond the CAUBO-informed allocations. These actuals (and projections to 29 August 2020) were entered on the Convergence Portal confirming our shared need for the full $41.6M allocated to the TAHSN system in Stage 1, and an additional $9M sought through Stage 2. The University has entered into an inter-institutional agreement with each of the affiliated hospitals/research institutes to enable transfer of funds upon receipt from TIPS.
Funding for this stage of CRCEF support will follow the same principles and processes as in Stages 1 and 2, with oversight from the Steering Committee and coordinated implementation by the Working Group. We will continue to develop common implementation parameters in consultation with TIPS.
Equity, Diversity & Inclusion in Decision-making on CRCEF Funding
It is important to understand that the University of Toronto and each of its affiliated health care institutions is a separately incorporated, independent employer with its own governance and management structures. Therefore, each institution is responsible for management of CRCEF funding allocated to it, and for complying with the program requirements. Information on each affiliated health care institution’s approach to equity, diversity and inclusion (EDI) can be found via the hyperlinks in section 2, above.
At Womens College Hospital, a deep commitment to equity, diversity and inclusion imbues all institutional processes and decision-making. In relation to decision-making on CRCEF, an advisory committee to the Vice-President, Research is overseeing the institutional approach to allocation of CRCEF funding to eligible claims. The committee comprises a diverse and representative cross-section of the hospital, and all members have completed unconscious bias training. Issues and questions related to EDI can be taken to the Committee as required.
The Hospitals’ strategy for equity, diversity and inclusion in decision-making for the use of CRCEF funds fits within its broader EDI framework that is incorporated into the numerous selection/allocation opportunities that are undertaken on a daily basis. For CRCEF, we ensure the following:
- Internal communications regarding the opportunity include language highlighting the commitment to equity, diversity and inclusion in managing CRCEF funds;
- Anyone involved in determining what claims may be brought forward is required to have undertaken unconscious bias training, particularly where the need exceeds the funds provided;
- Attestations are on file confirming that decisions are not negatively affected by a researcher’s inability to work during the pandemic due to child/family care or increased risk related to exposure to COVID-19; and
- Decision-making processes recognize and value research that is non-traditional or unconventional, based in Indigenous ways of knowing, outside the mainstream of the discipline, or focused on issues of gender, race or minority status. This will be achieved through measures including the following:
• Unconscious bias training/resources that include discussion of disciplinary bias;
•The multi-disciplinary IRLG membership includes knowledge of research in a range of fields that focus on questions of gender, race, and sexuality, as well as community-engaged research; and
•For Indigenous research, IRLG members will be follow SSHRC’s Principles for the Merit Review of Indigenous Research, and will seek out additional expertise if required.
The IRLG reviews the final submission to CRCEF program, and supporting documentation, to ensure that processes have been robust and transparent and that all potential beneficiaries have been treated equitably.
WCH Contact for CRCEF Program Compliance
At WCH, ultimate responsibility for the CRCEF program rests with the Vice-President, Research (Paula.Rochon@wchospital.ca).